IBEX shares surge 11.08% premarket after reporting record revenue, 46% EPS growth, and raising FY26 guidance.

IBEX surged 11.08% in premarket trading following the release of record quarterly results, including 17% revenue growth to $164.2 million and 46% adjusted EPS growth to $0.87, alongside raised fiscal year 2026 guidance for revenue ($620–$630 million) and adjusted EBITDA ($80–$82 million). The earnings call emphasized outperformance in high-margin verticals (HealthTech +35.1%, Travel +20.2%), offshore expansion, and AI-driven operational efficiency. Management highlighted strategic investments in AI solutions and India expansion, reinforcing long-term growth prospects. The beat on both revenue and EPS, coupled with improved margins and guidance upgrades, directly fueled the premarket rally.